Your provider chooses which one and at what dose based on your labs, health history, and goals
Since obesity is a chronic disease and anti-obesity medications are therefore designed for long-term use, maintaining all of the weight loss achieved with them is not usually possible when you stop taking them
Patil HR, Al Badarin FJ, Al Shami HA, Bhatti SK, Lavie CJ, Bell DS, OKeefe JH: Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus
32 A recent study clearly demonstrated the therapeutic potential of GLP-1R agonists in dementia treatment, as T2D patients treated with these agonists had reduced incidence of dementia compared to placebo
This general line of thinking is consistent with an emerging field of investigation in which TRPA1 channel-targeted drug discovery is applied for disease processes unrelated to sensory neuron function 20
Some studies suggest a potential link, while others provide limited evidence
